Pancreatic fate of a 125I-labelled mouse monoclonal antibody directed against pancreatic B-cell surface ganglioside(s) in control and diabetic rats

Laurence Ladriěre, Francine Malaisse-Lagae, Rodolfo Alejandro, Willy J. Malaisse

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The possible use of a mouse monoclonal antibody directed against rat pancreatic B-cell surface ganglioside(s) and labelled with radioactive iodine for selective imaging of the endocrine pancreas by a non-invasive procedure was investigated by following its pancreatic fate in experiments conducted either in vitro by incubation of rat isolated pancreatic islets, acinar tissue and pancreatic pieces or in vivo after intravenous injection of the 125I-labelled antibodies ([125I]γ-G). Although the binding of [125I]γ-G per μg protein was about one order of magnitude higher in isolated islets than in acinar tissue, no significant difference was detected when comparing pancreatic pieces or isolated islets from control animals and rats rendered diabetic by one or two prior administrations of streptozotocin (STZ rats). Likewise, except in one set of experiments, no significant difference was found between control animals and STZ rats, when measuring the radioactive content of the pancreatic gland, relative to that of plasma, 1-4 days after the intravenous injection of [125I]γ-G. These findings indicate that under the present experimental conditions, the mouse monoclonal antibody labelled with radioactive iodine does not appear to be a promising tool for selective imaging of the endocrine pancreas, e.g. by single photon emission computerized tomography.

Original languageEnglish
Pages (from-to)107-115
Number of pages9
JournalCell Biochemistry and Function
Volume19
Issue number2
DOIs
StatePublished - Jun 1 2001

Fingerprint

Gangliosides
Insulin-Secreting Cells
Rats
Monoclonal Antibodies
Cells
Islets of Langerhans
Intravenous Injections
Iodine
Animals
Tissue
Imaging techniques
Computerized tomography
Streptozocin
Single-Photon Emission-Computed Tomography
Photons
Experiments
Plasmas
Antibodies
Proteins

Keywords

  • I-labelled mouse monoclonal antibody
  • Pancreas
  • Pancreatic islets

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology

Cite this

Pancreatic fate of a 125I-labelled mouse monoclonal antibody directed against pancreatic B-cell surface ganglioside(s) in control and diabetic rats. / Ladriěre, Laurence; Malaisse-Lagae, Francine; Alejandro, Rodolfo; Malaisse, Willy J.

In: Cell Biochemistry and Function, Vol. 19, No. 2, 01.06.2001, p. 107-115.

Research output: Contribution to journalArticle

@article{36cab1173e6343a383c94a2fddd006e5,
title = "Pancreatic fate of a 125I-labelled mouse monoclonal antibody directed against pancreatic B-cell surface ganglioside(s) in control and diabetic rats",
abstract = "The possible use of a mouse monoclonal antibody directed against rat pancreatic B-cell surface ganglioside(s) and labelled with radioactive iodine for selective imaging of the endocrine pancreas by a non-invasive procedure was investigated by following its pancreatic fate in experiments conducted either in vitro by incubation of rat isolated pancreatic islets, acinar tissue and pancreatic pieces or in vivo after intravenous injection of the 125I-labelled antibodies ([125I]γ-G). Although the binding of [125I]γ-G per μg protein was about one order of magnitude higher in isolated islets than in acinar tissue, no significant difference was detected when comparing pancreatic pieces or isolated islets from control animals and rats rendered diabetic by one or two prior administrations of streptozotocin (STZ rats). Likewise, except in one set of experiments, no significant difference was found between control animals and STZ rats, when measuring the radioactive content of the pancreatic gland, relative to that of plasma, 1-4 days after the intravenous injection of [125I]γ-G. These findings indicate that under the present experimental conditions, the mouse monoclonal antibody labelled with radioactive iodine does not appear to be a promising tool for selective imaging of the endocrine pancreas, e.g. by single photon emission computerized tomography.",
keywords = "I-labelled mouse monoclonal antibody, Pancreas, Pancreatic islets",
author = "Laurence Ladriěre and Francine Malaisse-Lagae and Rodolfo Alejandro and Malaisse, {Willy J.}",
year = "2001",
month = "6",
day = "1",
doi = "10.1002/cbf.903",
language = "English",
volume = "19",
pages = "107--115",
journal = "Cell Biochemistry and Function",
issn = "0263-6484",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Pancreatic fate of a 125I-labelled mouse monoclonal antibody directed against pancreatic B-cell surface ganglioside(s) in control and diabetic rats

AU - Ladriěre, Laurence

AU - Malaisse-Lagae, Francine

AU - Alejandro, Rodolfo

AU - Malaisse, Willy J.

PY - 2001/6/1

Y1 - 2001/6/1

N2 - The possible use of a mouse monoclonal antibody directed against rat pancreatic B-cell surface ganglioside(s) and labelled with radioactive iodine for selective imaging of the endocrine pancreas by a non-invasive procedure was investigated by following its pancreatic fate in experiments conducted either in vitro by incubation of rat isolated pancreatic islets, acinar tissue and pancreatic pieces or in vivo after intravenous injection of the 125I-labelled antibodies ([125I]γ-G). Although the binding of [125I]γ-G per μg protein was about one order of magnitude higher in isolated islets than in acinar tissue, no significant difference was detected when comparing pancreatic pieces or isolated islets from control animals and rats rendered diabetic by one or two prior administrations of streptozotocin (STZ rats). Likewise, except in one set of experiments, no significant difference was found between control animals and STZ rats, when measuring the radioactive content of the pancreatic gland, relative to that of plasma, 1-4 days after the intravenous injection of [125I]γ-G. These findings indicate that under the present experimental conditions, the mouse monoclonal antibody labelled with radioactive iodine does not appear to be a promising tool for selective imaging of the endocrine pancreas, e.g. by single photon emission computerized tomography.

AB - The possible use of a mouse monoclonal antibody directed against rat pancreatic B-cell surface ganglioside(s) and labelled with radioactive iodine for selective imaging of the endocrine pancreas by a non-invasive procedure was investigated by following its pancreatic fate in experiments conducted either in vitro by incubation of rat isolated pancreatic islets, acinar tissue and pancreatic pieces or in vivo after intravenous injection of the 125I-labelled antibodies ([125I]γ-G). Although the binding of [125I]γ-G per μg protein was about one order of magnitude higher in isolated islets than in acinar tissue, no significant difference was detected when comparing pancreatic pieces or isolated islets from control animals and rats rendered diabetic by one or two prior administrations of streptozotocin (STZ rats). Likewise, except in one set of experiments, no significant difference was found between control animals and STZ rats, when measuring the radioactive content of the pancreatic gland, relative to that of plasma, 1-4 days after the intravenous injection of [125I]γ-G. These findings indicate that under the present experimental conditions, the mouse monoclonal antibody labelled with radioactive iodine does not appear to be a promising tool for selective imaging of the endocrine pancreas, e.g. by single photon emission computerized tomography.

KW - I-labelled mouse monoclonal antibody

KW - Pancreas

KW - Pancreatic islets

UR - http://www.scopus.com/inward/record.url?scp=0343832903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343832903&partnerID=8YFLogxK

U2 - 10.1002/cbf.903

DO - 10.1002/cbf.903

M3 - Article

VL - 19

SP - 107

EP - 115

JO - Cell Biochemistry and Function

JF - Cell Biochemistry and Function

SN - 0263-6484

IS - 2

ER -